Ligand validation:5MLA

GSP: 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE

GSP is a Ligand Of Interest in 5MLA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5MLA_GSP_A_202	87%	39%	0.105	0.978	1.22	1.18	2	2	0	0	100%	1
5VPZ_GSP_B_202	96%	54%	0.066	0.975	1.05	0.74	1	1	1	0	100%	1
4DSO_GSP_A_201	94%	20%	0.072	0.973	2.07	1.3	3	5	2	0	100%	0.9625
5VQ6_GSP_A_201	93%	55%	0.079	0.973	1.09	0.65	2	-	2	0	100%	1
7SCW_GSP_A_202	89%	30%	0.088	0.966	1.29	1.49	2	7	0	0	100%	1
5O2T_GSP_A_202	87%	39%	0.105	0.978	1.22	1.18	2	2	0	0	100%	1
4TMV_GSP_B_901	98%	43%	0.06	0.984	1.09	1.11	2	3	1	0	100%	1
1AS0_GSP_A_355	98%	9%	0.064	0.986	1.58	2.81	7	8	1	0	100%	1
2HF8_GSP_B_300	98%	18%	0.053	0.974	2.07	1.51	4	7	2	0	100%	1
8VGA_GSP_A_402	98%	19%	0.057	0.978	1.83	1.6	3	7	1	0	100%	1
1RLU_GSP_A_401	98%	21%	0.065	0.984	1.89	1.4	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.